Editorial
Accepted on 13 Mar 2025
Research Topic: Immunotherapy: Up to Date Progress in Childhood and Hematological Malignancies
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1584101
Type at least 3 characters
1,390 articles
Articles
Brief Research Report
Accepted on 13 Mar 2025
Amyloid Precursor-Like Protein 2 Expression in Macrophages: Differentiation and M1/M2 Macrophage Dynamics
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1570955
Review
Published on 11 Mar 2025
Neoantigens: new hope for cancer therapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1531592
- 214 views
Case Report
Accepted on 10 Mar 2025
Lasting complete response to pembrolizumab in mismatch repair-deficient cardiac sarcoma: a genomic characterization
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1485386
Case Report
Accepted on 10 Mar 2025
Promising Outcomes of the PD-L1 inhibitor Socazolimab in Recurrent and Metastatic Cervical Cancer: A Case Report
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1541760
Case Report
Published on 10 Mar 2025
Case Report: Metastatic succinate dehydrogenase–deficient gastrointestinal stromal tumor treated with chemotherapy and immune checkpoint inhibitor
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1549232
- 293 views
Original Research
Published on 10 Mar 2025
Circulating cell-free DNA methylation analysis of pancreatic cancer patients for early noninvasive diagnosis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1552426
- 332 views
Original Research
Published on 10 Mar 2025
Immune checkpoint inhibitor plus tyrosine kinase inhibitor with or without transarterial chemoembolization for unresectable hepatocellular carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1385304
- 148 views
Case Report
Accepted on 06 Mar 2025
Emapalumab for severe cytokine release syndrome in solid tumor CAR-T: a case report
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1543622
Case Report
Published on 06 Mar 2025
Tislelizumab-induced type 1 diabetic ketoacidosis in a patient with small cell lung cancer: a case report
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1498701
- 254 views
Original Research
Published on 05 Mar 2025
Integrated single-cell analysis reveals the regulatory network of disulfidptosis-related lncRNAs in bladder cancer: constructing a prognostic model and predicting treatment response
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1527036
- 228 views
Original Research
Accepted on 04 Mar 2025
Single-cell sequencing reveals the role of aggrephagy-related patterns in tumor microenvironment, prognosis and immunotherapy in endometrial cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1560625
Review
Published on 04 Mar 2025
Research and progress of microRNA-136 in metastatic tumors
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1555270
- 153 views
Case Report
Accepted on 03 Mar 2025
A Case of Camrelizumab-Induced Anaphylaxis and Successful Rechallenge: A Case Report and Literature Review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1537205
Original Research
Accepted on 28 Feb 2025
Integrating multi-omics and machine learning methods reveals the metabolism of amino acids and derivatives-related signature in colorectal cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1565090
Original Research
Accepted on 28 Feb 2025
Enhanced anti-tumor efficacy of "IL-15 and CCL19" -secreting CAR-T cells in human glioblastoma orthotopic xenograft model
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1539055